Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell

Yuji Nakata1, Kensuke Kondoh, Sachiko Fukushima

  • 1Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

Experimental Hematology
|November 27, 2007
PubMed
Abstract

Insights

Mutated D4-guanine diphosphate (GDP)-dissociation inhibitor (GDI) accelerates leukemic cell invasion by disrupting normal Rho-GDI function. This dominant-negative mutation enhances cell motility and adhesion, leading to increased cancer spread.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Rho GTPases play a role in cancer cell motility and adhesion.
  • D4-guanine diphosphate (GDP)-dissociation inhibitor (GDI) is a regulator of Rho GTPases.
  • Mutations in D4-GDI may influence cancer invasion.

Purpose of the Study:

  • To investigate the role of mutated D4-GDI in leukemic cell invasion.
  • To analyze the functional alterations of mutated D4-GDI.
  • To determine the effect of mutated D4-GDI on cell motility and adhesion.

Main Methods:

  • Identified point mutations in the D4-GDI gene in Reh leukemic cells.
  • Investigated GDP dissociation activity of wild-type (wt) and mutated (mt) D4-GDI.
  • Utilized a mouse model with Raji cells transfected with wt or mt D4-GDI vectors.
  • Assessed cell adhesiveness, motility, and Rho activation status.

Main Results:

  • Two point mutations (V68L and V69A) in D4-GDI were identified, conferring dominant-negative activity.
  • Mice inoculated with mt D4-GDI-transfected Raji cells showed accelerated paralysis and increased hepatic invasion (80%) compared to wt D4-GDI cells (0%).
  • Mutated D4-GDI enhanced cell adhesiveness and motility, while wild-type D4-GDI decreased motility.

Conclusions:

  • Mutated D4-GDI acts as a dominant-negative inhibitor of wild-type D4-GDI.
  • This mutation accelerates leukemic cell invasion by modulating the Rho GTPase pathway and cytoskeletal machinery.
  • The findings highlight a novel mechanism of cancer invasion driven by D4-GDI mutations.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...